References
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A (2014) Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64(2):83–103
Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107(1):265–276
Carbone A, Spina M, Gloghini A, Tirelli U (2011) Classical Hodgkin’s lymphoma arising in different host’s conditions: pathobiology parameters, therapeutic options, and outcome. Am J Hematol 86(2):170–179
Zhou R, Ng A, Constine LS et al (2016) A comparative evaluation of normal tissue doses for patients receiving radiation therapy for Hodgkin lymphoma on the childhood cancer survivor study and recent Children’s Oncology Group trials. Int J Radiat Oncol Biol Phys 95(2):707–711
Moskowitz CS, Chou JF, Wolden SL et al (2014) Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol 32(21):2217–2223
Armstrong GT, Oeffinger KC, Chen Y et al (2013) Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol 31(29):3673–3680
Meadows AT, Friedman DL, Neglia JP et al (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27(14):2356–2362
Yahalom J, Mauch P (2002) The involved field is back: issues in delineating the radiation field in Hodgkin’s disease. Ann Oncol 13(Suppl 1):79–83
Girinsky T, Specht L, Ghalibafian M et al (2008) The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 88(2):202–210
Dharmarajan KV, Friedman DL, Schwartz CL et al (2015) Patterns of relapse from a phase 3 study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys 92(1):60–66
Charpentier AM, Friedman DL, Wolden S et al (2016) Predictive factor analysis of response-adapted radiation therapy for chemotherapy-sensitive pediatric Hodgkin lymphoma: analysis of the Children’s Oncology Group AHOD 0031 trial. Int J Radiat Oncol Biol Phys 96(5):943–950
Schwartz CL, Chen L, McCarten K et al (2016) Childhood Hodgkin International Prognostic Score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 64:e26278
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Guss, Z.D., Chen, Q., Hoppe, B., Terezakis, S.A. (2019). Pediatric Hodgkin Lymphoma. In: Terezakis, S., MacDonald, S. (eds) Target Volume Delineation for Pediatric Cancers. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-69140-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-69140-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69139-8
Online ISBN: 978-3-319-69140-4
eBook Packages: MedicineMedicine (R0)